Ruder Finn Health Care is one of the firm's oldest and largest divisions as well as one of the country's strongest PR practitioners in providing health care communications services to most of the world's leading biopharmaceutical companies, hospitals, medical instrument manufacturers, physician associations and patient/disease awareness groups.

Comprised of professionals with diverse backgrounds in such fields as journalism, pharmacy, public policy, research and marketing, this division's expertise includes: launching new drugs and devices; communications support for product withdrawals; counseling clients through regulatory review; patient education; international core programs; forming strategic alliances; patient recruitment for clinical trials; building client relationships with activist groups; professional education and peer selling.

Current and recent past clients include Sandoz Pharmaceuticals, Ciba-Geigy, Glaxo-Wellcome, Pfizer, Rhone-Poulenc, SmithKline Beecham, Schering-Plough, Boehringer Ingelheim, and the newly-merged identity of Sandoz and Ciba-Geigy, Novartis.